LIPOSYN III 30% Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Liposyn Iii 30%, and when can generic versions of Liposyn Iii 30% launch?

Liposyn Iii 30% is a drug marketed by Hospira and is included in one NDA.

The generic ingredient in LIPOSYN III 30% is soybean oil. There are thirteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the soybean oil profile page.

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for LIPOSYN III 30%?
What are the global sales for LIPOSYN III 30%?
What is Average Wholesale Price for LIPOSYN III 30%?

Summary for LIPOSYN III 30%

US Patents:	0
Applicants:	1
NDAs:	1
Clinical Trials:	4
Formulation / Manufacturing:	see details
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for LIPOSYN III 30%
DailyMed Link:	LIPOSYN III 30% at DailyMed

Drug patent expirations by year for LIPOSYN III 30%

Recent Clinical Trials for LIPOSYN III 30%

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
The Cleveland Clinic	Early Phase 1
Pennington Biomedical Research Center	Early Phase 1
The University of Texas Health Science Center at San Antonio	N/A

See all LIPOSYN III 30% clinical trials

US Patents and Regulatory Information for LIPOSYN III 30%

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hospira	LIPOSYN III 30%	soybean oil	INJECTABLE;INJECTION	020181-001	Jan 13, 1998		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for LIPOSYN III 30%

When does loss-of-exclusivity occur for LIPOSYN III 30%?

Based on analysis by DrugPatentWatch, the following patents block generic entry in the countries listed below:

Argentina

Patent: 0632
Patent: PORTADOR DE CARTUCHO E INYECTOR DEL TIPO DE BOLIGRAFO
Estimated Expiration: ⤷ Sign Up

Australia

Patent: 13247058
Patent: Cartridge holder and pen-type injector
Estimated Expiration: ⤷ Sign Up

Brazil

Patent: 2014025232
Patent: suporte de cartucho
Estimated Expiration: ⤷ Sign Up

China

Patent: 4220113
Patent: Cartridge holder and pen-type injector
Estimated Expiration: ⤷ Sign Up

Denmark

Patent: 36259
Estimated Expiration: ⤷ Sign Up

European Patent Office

Patent: 36259
Patent: SUPPORT DE CARTOUCHE ET INJECTEUR DE TYPE STYLO (CARTRIDGE HOLDER AND PEN-TYPE INJECTOR)
Estimated Expiration: ⤷ Sign Up

Hong Kong

Patent: 01769
Patent: 藥筒保持器和筆式注射器 (CARTRIDGE HOLDER AND PEN-TYPE INJECTOR)
Estimated Expiration: ⤷ Sign Up

Hungary

Patent: 28339
Estimated Expiration: ⤷ Sign Up

Israel

Patent: 4450
Patent: מחזיק מחסנית ומזרק בצורת עט (Cartridge holder and pen-type injector)
Estimated Expiration: ⤷ Sign Up

Japan

Patent: 73462
Estimated Expiration: ⤷ Sign Up

Patent: 15516201
Patent: カートリッジホルダおよびペン型注射器
Estimated Expiration: ⤷ Sign Up

Mexico

Patent: 1343
Patent: PORTA-CARTUCHO E INYECTOR DE TIPO PLUMA. (CARTRIDGE HOLDER AND PEN-TYPE INJECTOR.)
Estimated Expiration: ⤷ Sign Up

Patent: 14012226
Patent: PORTA-CARTUCHO E INYECTOR DE TIPO PLUMA. (CARTRIDGE HOLDER AND PEN-TYPE INJECTOR.)
Estimated Expiration: ⤷ Sign Up

Poland

Patent: 36259
Estimated Expiration: ⤷ Sign Up

Russian Federation

Patent: 30597
Patent: ДЕРЖАТЕЛЬ КАРТРИДЖА И ШПРИЦ-РУЧКА (CARTRIDGE HOLDER AND HANDLE SYRINGE)
Estimated Expiration: ⤷ Sign Up

Patent: 14144631
Patent: ДЕРЖАТЕЛЬ КАРТРИДЖА И ШПРИЦ-РУЧКА
Estimated Expiration: ⤷ Sign Up

South Korea

Patent: 2124661
Estimated Expiration: ⤷ Sign Up

Patent: 150003199
Patent: CARTRIDGE HOLDER AND PEN-TYPE INJECTOR
Estimated Expiration: ⤷ Sign Up

Spain

Patent: 88510
Estimated Expiration: ⤷ Sign Up

Taiwan

Patent: 68466
Estimated Expiration: ⤷ Sign Up

Patent: 1402163
Patent: Cartridge holder and pen-type injector
Estimated Expiration: ⤷ Sign Up

Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.

See the table below for additional patents covering LIPOSYN III 30% around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Australia	2013247058	Cartridge holder and pen-type injector	⤷ Sign Up
Hong Kong	1201769	藥筒保持器和筆式注射器 (CARTRIDGE HOLDER AND PEN-TYPE INJECTOR)	⤷ Sign Up
Mexico	2014012226	PORTA-CARTUCHO E INYECTOR DE TIPO PLUMA. (CARTRIDGE HOLDER AND PEN-TYPE INJECTOR.)	⤷ Sign Up
Denmark	2836259		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for LIPOSYN III 30%

Recent Clinical Trials for LIPOSYN III 30%

When does loss-of-exclusivity occur for LIPOSYN III 30%?

Make Better Decisions: Try a trial or see plans & pricing